Investing

Teva, Gilead Sciences Tumble into Monday's 52-Week Low Club

January 23, 2017: Here are four stocks trading with relatively heavy volume among 56 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by about 8 to 7 and on the Nasdaq decliners led advancers by about 4 to 3.

DryShips Inc. (NASDAQ: DRYS) dropped about 35% on Monday to post a new 52-week low of $5.28 against a 52-week high of $278.40 and a Friday close of $1.01. Volume of around 12.5 million was about equal to the daily average of around 13 million. Shares began trading this morning after a 1-for-8 reverse stock split that valued the new shares at about $8.00.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) dropped about 3.4% Monday to post a new 52-week low of $32.11 after closing Friday at $33.23. The 52-week high is $64.31. Volume of around 11 million was about 10% above the daily average of around 10.4 million shares traded. The company had no specific news.

Endo International plc (NASDAQ: ENDP) dropped about 6.6% on Monday to post a new 52-week low of $11.52 after closing at $12.34 on Friday. Volume was about 75% above the daily average of around 5.8 million. The company announced a settlement in an FTC lawsuit related to payments to competitors to delay introducing new generic drugs.

Gilead Sciences Inc. (NASDAQ: GILD) dropped about 1% Monday, to post a new 52-week low of $70.30 after closing at $71.01 on Friday. The stock’s 52-week high is $103.10. Volume was about 10% below the daily average of around 9.8 million shares. The company had no specific news Monday.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.